• レポートコード:QY2207E09882 • 出版社/出版日:QYResearch / 2022年7月 • レポート形態:英文、PDF、107ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療機器 |
Single User | ¥735,000 (USD4,900) | ▷ お問い合わせ |
Multi User | ¥1,102,500 (USD7,350) | ▷ お問い合わせ |
Enterprise License | ¥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界の神経血管介入装置の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に神経血管介入装置の世界市場のxxx%を占める「塞栓コイル」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。 中国の神経血管介入装置の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの神経血管介入装置市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの神経血管介入装置市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。 神経血管介入装置のグローバル主要メーカーには、W.L. Gore & Associates、Abbott Laboratories、Stryker Corporation、Medtronic PLC、Terumo Corporation、Johnson & Johnson、Penumbra, Inc.、Boston Scientific Corporation、Merit Medical Systems, Inc.、Microport Scientific Corporation、Cardinal Healthなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。 神経血管介入装置市場は、種類と用途によって区分されます。世界の神経血管介入装置市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 塞栓コイル、頸動脈ステント、頭蓋内ステント、分流器、嚢内装置、その他 【用途別セグメント】 病院、クリニック、外来外科センター、その他 【掲載地域】 北米:アメリカ、カナダ ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米:メキシコ、ブラジル、アルゼンチン 中東・アフリカ:トルコ、サウジアラビア、UAE 【目次(一部)】 ・調査の範囲 - 神経血管介入装置製品概要 - 種類別市場(塞栓コイル、頸動脈ステント、頭蓋内ステント、分流器、嚢内装置、その他) - 用途別市場(病院、クリニック、外来外科センター、その他) - 調査の目的 ・エグゼクティブサマリー - 世界の神経血管介入装置販売量予測2017-2028 - 世界の神経血管介入装置売上予測2017-2028 - 神経血管介入装置の地域別販売量 - 神経血管介入装置の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別神経血管介入装置販売量 - 主要メーカー別神経血管介入装置売上 - 主要メーカー別神経血管介入装置価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模(塞栓コイル、頸動脈ステント、頭蓋内ステント、分流器、嚢内装置、その他) - 神経血管介入装置の種類別販売量 - 神経血管介入装置の種類別売上 - 神経血管介入装置の種類別価格 ・用途別市場規模(病院、クリニック、外来外科センター、その他) - 神経血管介入装置の用途別販売量 - 神経血管介入装置の用途別売上 - 神経血管介入装置の用途別価格 ・北米市場 - 北米の神経血管介入装置市場規模(種類別、用途別) - 主要国別の神経血管介入装置市場規模(アメリカ、カナダ) ・ヨーロッパ市場 - ヨーロッパの神経血管介入装置市場規模(種類別、用途別) - 主要国別の神経血管介入装置市場規模(ドイツ、フランス、イギリス、イタリア、ロシア) ・アジア太平洋市場 - アジア太平洋の神経血管介入装置市場規模(種類別、用途別) - 主要国別の神経血管介入装置市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア) ・中南米市場 - 中南米の神経血管介入装置市場規模(種類別、用途別) - 主要国別の神経血管介入装置市場規模(メキシコ、ブラジル、アルゼンチン) ・中東・アフリカ市場 - 中東・アフリカの神経血管介入装置市場規模(種類別、用途別) - 主要国別の神経血管介入装置市場規模(トルコ、サウジアラビア) ・企業情報 W.L. Gore & Associates、Abbott Laboratories、Stryker Corporation、Medtronic PLC、Terumo Corporation、Johnson & Johnson、Penumbra, Inc.、Boston Scientific Corporation、Merit Medical Systems, Inc.、Microport Scientific Corporation、Cardinal Health ・産業チェーン及び販売チャネル分析 - 神経血管介入装置の産業チェーン分析 - 神経血管介入装置の原材料 - 神経血管介入装置の生産プロセス - 神経血管介入装置の販売及びマーケティング - 神経血管介入装置の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 神経血管介入装置の産業動向 - 神経血管介入装置のマーケットドライバー - 神経血管介入装置の課題 - 神経血管介入装置の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Neurovascular Interventional Devices Market
Due to the COVID-19 pandemic, the global Neurovascular Interventional Devices market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Embolization Coils accounting for % of the Neurovascular Interventional Devices global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Neurovascular Interventional Devices market size is valued at US$ million in 2021, while the US and Europe Neurovascular Interventional Devices are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Neurovascular Interventional Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Neurovascular Interventional Devices include W.L. Gore & Associates, Abbott Laboratories, Stryker Corporation, Medtronic PLC, Terumo Corporation, Johnson & Johnson, Penumbra, Inc., Boston Scientific Corporation and Merit Medical Systems, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Neurovascular Interventional Devices Scope and Segment
Neurovascular Interventional Devices market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Neurovascular Interventional Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Embolization Coils
Carotid Stents
Intracranial Stents
Flow Diverters
Intrasaccular Devices
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Company
W.L. Gore & Associates
Abbott Laboratories
Stryker Corporation
Medtronic PLC
Terumo Corporation
Johnson & Johnson
Penumbra, Inc.
Boston Scientific Corporation
Merit Medical Systems, Inc.
Microport Scientific Corporation
Cardinal Health
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Neurovascular Interventional Devices Product Introduction
1.2 Market by Type
1.2.1 Global Neurovascular Interventional Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Embolization Coils
1.2.3 Carotid Stents
1.2.4 Intracranial Stents
1.2.5 Flow Diverters
1.2.6 Intrasaccular Devices
1.2.7 Others
1.3 Market by Application
1.3.1 Global Neurovascular Interventional Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Neurovascular Interventional Devices Sales Estimates and Forecasts 2017-2028
2.2 Global Neurovascular Interventional Devices Revenue Estimates and Forecasts 2017-2028
2.3 Global Neurovascular Interventional Devices Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Neurovascular Interventional Devices Sales by Region
2.4.1 Global Neurovascular Interventional Devices Sales by Region (2017-2022)
2.4.2 Global Sales Neurovascular Interventional Devices by Region (2023-2028)
2.5 Global Neurovascular Interventional Devices Revenue by Region
2.5.1 Global Neurovascular Interventional Devices Revenue by Region (2017-2022)
2.5.2 Global Neurovascular Interventional Devices Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Neurovascular Interventional Devices Sales by Manufacturers
3.1.1 Global Top Neurovascular Interventional Devices Manufacturers by Sales (2017-2022)
3.1.2 Global Neurovascular Interventional Devices Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Neurovascular Interventional Devices in 2021
3.2 Global Neurovascular Interventional Devices Revenue by Manufacturers
3.2.1 Global Neurovascular Interventional Devices Revenue by Manufacturers (2017-2022)
3.2.2 Global Neurovascular Interventional Devices Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Neurovascular Interventional Devices Revenue in 2021
3.3 Global Neurovascular Interventional Devices Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Neurovascular Interventional Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Neurovascular Interventional Devices Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Neurovascular Interventional Devices Sales by Type
4.1.1 Global Neurovascular Interventional Devices Historical Sales by Type (2017-2022)
4.1.2 Global Neurovascular Interventional Devices Forecasted Sales by Type (2023-2028)
4.1.3 Global Neurovascular Interventional Devices Sales Market Share by Type (2017-2028)
4.2 Global Neurovascular Interventional Devices Revenue by Type
4.2.1 Global Neurovascular Interventional Devices Historical Revenue by Type (2017-2022)
4.2.2 Global Neurovascular Interventional Devices Forecasted Revenue by Type (2023-2028)
4.2.3 Global Neurovascular Interventional Devices Revenue Market Share by Type (2017-2028)
4.3 Global Neurovascular Interventional Devices Price by Type
4.3.1 Global Neurovascular Interventional Devices Price by Type (2017-2022)
4.3.2 Global Neurovascular Interventional Devices Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Neurovascular Interventional Devices Sales by Application
5.1.1 Global Neurovascular Interventional Devices Historical Sales by Application (2017-2022)
5.1.2 Global Neurovascular Interventional Devices Forecasted Sales by Application (2023-2028)
5.1.3 Global Neurovascular Interventional Devices Sales Market Share by Application (2017-2028)
5.2 Global Neurovascular Interventional Devices Revenue by Application
5.2.1 Global Neurovascular Interventional Devices Historical Revenue by Application (2017-2022)
5.2.2 Global Neurovascular Interventional Devices Forecasted Revenue by Application (2023-2028)
5.2.3 Global Neurovascular Interventional Devices Revenue Market Share by Application (2017-2028)
5.3 Global Neurovascular Interventional Devices Price by Application
5.3.1 Global Neurovascular Interventional Devices Price by Application (2017-2022)
5.3.2 Global Neurovascular Interventional Devices Price Forecast by Application (2023-2028)
6 North America
6.1 North America Neurovascular Interventional Devices Market Size by Type
6.1.1 North America Neurovascular Interventional Devices Sales by Type (2017-2028)
6.1.2 North America Neurovascular Interventional Devices Revenue by Type (2017-2028)
6.2 North America Neurovascular Interventional Devices Market Size by Application
6.2.1 North America Neurovascular Interventional Devices Sales by Application (2017-2028)
6.2.2 North America Neurovascular Interventional Devices Revenue by Application (2017-2028)
6.3 North America Neurovascular Interventional Devices Market Size by Country
6.3.1 North America Neurovascular Interventional Devices Sales by Country (2017-2028)
6.3.2 North America Neurovascular Interventional Devices Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Neurovascular Interventional Devices Market Size by Type
7.1.1 Europe Neurovascular Interventional Devices Sales by Type (2017-2028)
7.1.2 Europe Neurovascular Interventional Devices Revenue by Type (2017-2028)
7.2 Europe Neurovascular Interventional Devices Market Size by Application
7.2.1 Europe Neurovascular Interventional Devices Sales by Application (2017-2028)
7.2.2 Europe Neurovascular Interventional Devices Revenue by Application (2017-2028)
7.3 Europe Neurovascular Interventional Devices Market Size by Country
7.3.1 Europe Neurovascular Interventional Devices Sales by Country (2017-2028)
7.3.2 Europe Neurovascular Interventional Devices Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Neurovascular Interventional Devices Market Size by Type
8.1.1 Asia Pacific Neurovascular Interventional Devices Sales by Type (2017-2028)
8.1.2 Asia Pacific Neurovascular Interventional Devices Revenue by Type (2017-2028)
8.2 Asia Pacific Neurovascular Interventional Devices Market Size by Application
8.2.1 Asia Pacific Neurovascular Interventional Devices Sales by Application (2017-2028)
8.2.2 Asia Pacific Neurovascular Interventional Devices Revenue by Application (2017-2028)
8.3 Asia Pacific Neurovascular Interventional Devices Market Size by Region
8.3.1 Asia Pacific Neurovascular Interventional Devices Sales by Region (2017-2028)
8.3.2 Asia Pacific Neurovascular Interventional Devices Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Neurovascular Interventional Devices Market Size by Type
9.1.1 Latin America Neurovascular Interventional Devices Sales by Type (2017-2028)
9.1.2 Latin America Neurovascular Interventional Devices Revenue by Type (2017-2028)
9.2 Latin America Neurovascular Interventional Devices Market Size by Application
9.2.1 Latin America Neurovascular Interventional Devices Sales by Application (2017-2028)
9.2.2 Latin America Neurovascular Interventional Devices Revenue by Application (2017-2028)
9.3 Latin America Neurovascular Interventional Devices Market Size by Country
9.3.1 Latin America Neurovascular Interventional Devices Sales by Country (2017-2028)
9.3.2 Latin America Neurovascular Interventional Devices Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Neurovascular Interventional Devices Market Size by Type
10.1.1 Middle East and Africa Neurovascular Interventional Devices Sales by Type (2017-2028)
10.1.2 Middle East and Africa Neurovascular Interventional Devices Revenue by Type (2017-2028)
10.2 Middle East and Africa Neurovascular Interventional Devices Market Size by Application
10.2.1 Middle East and Africa Neurovascular Interventional Devices Sales by Application (2017-2028)
10.2.2 Middle East and Africa Neurovascular Interventional Devices Revenue by Application (2017-2028)
10.3 Middle East and Africa Neurovascular Interventional Devices Market Size by Country
10.3.1 Middle East and Africa Neurovascular Interventional Devices Sales by Country (2017-2028)
10.3.2 Middle East and Africa Neurovascular Interventional Devices Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 W.L. Gore & Associates
11.1.1 W.L. Gore & Associates Corporation Information
11.1.2 W.L. Gore & Associates Overview
11.1.3 W.L. Gore & Associates Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 W.L. Gore & Associates Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 W.L. Gore & Associates Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Corporation Information
11.2.2 Abbott Laboratories Overview
11.2.3 Abbott Laboratories Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Abbott Laboratories Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Laboratories Recent Developments
11.3 Stryker Corporation
11.3.1 Stryker Corporation Corporation Information
11.3.2 Stryker Corporation Overview
11.3.3 Stryker Corporation Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Stryker Corporation Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Stryker Corporation Recent Developments
11.4 Medtronic PLC
11.4.1 Medtronic PLC Corporation Information
11.4.2 Medtronic PLC Overview
11.4.3 Medtronic PLC Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Medtronic PLC Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Medtronic PLC Recent Developments
11.5 Terumo Corporation
11.5.1 Terumo Corporation Corporation Information
11.5.2 Terumo Corporation Overview
11.5.3 Terumo Corporation Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Terumo Corporation Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Terumo Corporation Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Overview
11.6.3 Johnson & Johnson Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Johnson & Johnson Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson & Johnson Recent Developments
11.7 Penumbra, Inc.
11.7.1 Penumbra, Inc. Corporation Information
11.7.2 Penumbra, Inc. Overview
11.7.3 Penumbra, Inc. Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Penumbra, Inc. Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Penumbra, Inc. Recent Developments
11.8 Boston Scientific Corporation
11.8.1 Boston Scientific Corporation Corporation Information
11.8.2 Boston Scientific Corporation Overview
11.8.3 Boston Scientific Corporation Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Boston Scientific Corporation Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Boston Scientific Corporation Recent Developments
11.9 Merit Medical Systems, Inc.
11.9.1 Merit Medical Systems, Inc. Corporation Information
11.9.2 Merit Medical Systems, Inc. Overview
11.9.3 Merit Medical Systems, Inc. Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Merit Medical Systems, Inc. Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Merit Medical Systems, Inc. Recent Developments
11.10 Microport Scientific Corporation
11.10.1 Microport Scientific Corporation Corporation Information
11.10.2 Microport Scientific Corporation Overview
11.10.3 Microport Scientific Corporation Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Microport Scientific Corporation Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Microport Scientific Corporation Recent Developments
11.11 Cardinal Health
11.11.1 Cardinal Health Corporation Information
11.11.2 Cardinal Health Overview
11.11.3 Cardinal Health Neurovascular Interventional Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Cardinal Health Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Cardinal Health Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Neurovascular Interventional Devices Industry Chain Analysis
12.2 Neurovascular Interventional Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Neurovascular Interventional Devices Production Mode & Process
12.4 Neurovascular Interventional Devices Sales and Marketing
12.4.1 Neurovascular Interventional Devices Sales Channels
12.4.2 Neurovascular Interventional Devices Distributors
12.5 Neurovascular Interventional Devices Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Neurovascular Interventional Devices Industry Trends
13.2 Neurovascular Interventional Devices Market Drivers
13.3 Neurovascular Interventional Devices Market Challenges
13.4 Neurovascular Interventional Devices Market Restraints
14 Key Findings in The Global Neurovascular Interventional Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Neurovascular Interventional Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Embolization Coils
Table 3. Major Manufacturers of Carotid Stents
Table 4. Major Manufacturers of Intracranial Stents
Table 5. Major Manufacturers of Flow Diverters
Table 6. Major Manufacturers of Intrasaccular Devices
Table 7. Major Manufacturers of Others
Table 8. Global Neurovascular Interventional Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Neurovascular Interventional Devices Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Neurovascular Interventional Devices Sales by Region (2017-2022) & (K Units)
Table 11. Global Neurovascular Interventional Devices Sales Market Share by Region (2017-2022)
Table 12. Global Neurovascular Interventional Devices Sales by Region (2023-2028) & (K Units)
Table 13. Global Neurovascular Interventional Devices Sales Market Share by Region (2023-2028)
Table 14. Global Neurovascular Interventional Devices Revenue by Region (2017-2022) & (US$ Million)
Table 15. Global Neurovascular Interventional Devices Revenue Market Share by Region (2017-2022)
Table 16. Global Neurovascular Interventional Devices Revenue by Region (2023-2028) & (US$ Million)
Table 17. Global Neurovascular Interventional Devices Revenue Market Share by Region (2023-2028)
Table 18. Global Neurovascular Interventional Devices Sales by Manufacturers (2017-2022) & (K Units)
Table 19. Global Neurovascular Interventional Devices Sales Share by Manufacturers (2017-2022)
Table 20. Global Neurovascular Interventional Devices Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 21. Global Neurovascular Interventional Devices Revenue Share by Manufacturers (2017-2022)
Table 22. Neurovascular Interventional Devices Price by Manufacturers (2017-2022) &(US$/Unit)
Table 23. Global Neurovascular Interventional Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Neurovascular Interventional Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurovascular Interventional Devices as of 2021)
Table 25. Neurovascular Interventional Devices Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Neurovascular Interventional Devices Product Offered
Table 27. Date of Manufacturers Enter into Neurovascular Interventional Devices Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Neurovascular Interventional Devices Sales by Type (2017-2022) & (K Units)
Table 30. Global Neurovascular Interventional Devices Sales by Type (2023-2028) & (K Units)
Table 31. Global Neurovascular Interventional Devices Sales Share by Type (2017-2022)
Table 32. Global Neurovascular Interventional Devices Sales Share by Type (2023-2028)
Table 33. Global Neurovascular Interventional Devices Revenue by Type (2017-2022) & (US$ Million)
Table 34. Global Neurovascular Interventional Devices Revenue by Type (2023-2028) & (US$ Million)
Table 35. Global Neurovascular Interventional Devices Revenue Share by Type (2017-2022)
Table 36. Global Neurovascular Interventional Devices Revenue Share by Type (2023-2028)
Table 37. Neurovascular Interventional Devices Price by Type (2017-2022) & (US$/Unit)
Table 38. Global Neurovascular Interventional Devices Price Forecast by Type (2023-2028) & (US$/Unit)
Table 39. Global Neurovascular Interventional Devices Sales by Application (2017-2022) & (K Units)
Table 40. Global Neurovascular Interventional Devices Sales by Application (2023-2028) & (K Units)
Table 41. Global Neurovascular Interventional Devices Sales Share by Application (2017-2022)
Table 42. Global Neurovascular Interventional Devices Sales Share by Application (2023-2028)
Table 43. Global Neurovascular Interventional Devices Revenue by Application (2017-2022) & (US$ Million)
Table 44. Global Neurovascular Interventional Devices Revenue by Application (2023-2028) & (US$ Million)
Table 45. Global Neurovascular Interventional Devices Revenue Share by Application (2017-2022)
Table 46. Global Neurovascular Interventional Devices Revenue Share by Application (2023-2028)
Table 47. Neurovascular Interventional Devices Price by Application (2017-2022) & (US$/Unit)
Table 48. Global Neurovascular Interventional Devices Price Forecast by Application (2023-2028) & (US$/Unit)
Table 49. North America Neurovascular Interventional Devices Sales by Type (2017-2022) & (K Units)
Table 50. North America Neurovascular Interventional Devices Sales by Type (2023-2028) & (K Units)
Table 51. North America Neurovascular Interventional Devices Revenue by Type (2017-2022) & (US$ Million)
Table 52. North America Neurovascular Interventional Devices Revenue by Type (2023-2028) & (US$ Million)
Table 53. North America Neurovascular Interventional Devices Sales by Application (2017-2022) & (K Units)
Table 54. North America Neurovascular Interventional Devices Sales by Application (2023-2028) & (K Units)
Table 55. North America Neurovascular Interventional Devices Revenue by Application (2017-2022) & (US$ Million)
Table 56. North America Neurovascular Interventional Devices Revenue by Application (2023-2028) & (US$ Million)
Table 57. North America Neurovascular Interventional Devices Sales by Country (2017-2022) & (K Units)
Table 58. North America Neurovascular Interventional Devices Sales by Country (2023-2028) & (K Units)
Table 59. North America Neurovascular Interventional Devices Revenue by Country (2017-2022) & (US$ Million)
Table 60. North America Neurovascular Interventional Devices Revenue by Country (2023-2028) & (US$ Million)
Table 61. Europe Neurovascular Interventional Devices Sales by Type (2017-2022) & (K Units)
Table 62. Europe Neurovascular Interventional Devices Sales by Type (2023-2028) & (K Units)
Table 63. Europe Neurovascular Interventional Devices Revenue by Type (2017-2022) & (US$ Million)
Table 64. Europe Neurovascular Interventional Devices Revenue by Type (2023-2028) & (US$ Million)
Table 65. Europe Neurovascular Interventional Devices Sales by Application (2017-2022) & (K Units)
Table 66. Europe Neurovascular Interventional Devices Sales by Application (2023-2028) & (K Units)
Table 67. Europe Neurovascular Interventional Devices Revenue by Application (2017-2022) & (US$ Million)
Table 68. Europe Neurovascular Interventional Devices Revenue by Application (2023-2028) & (US$ Million)
Table 69. Europe Neurovascular Interventional Devices Sales by Country (2017-2022) & (K Units)
Table 70. Europe Neurovascular Interventional Devices Sales by Country (2023-2028) & (K Units)
Table 71. Europe Neurovascular Interventional Devices Revenue by Country (2017-2022) & (US$ Million)
Table 72. Europe Neurovascular Interventional Devices Revenue by Country (2023-2028) & (US$ Million)
Table 73. Asia Pacific Neurovascular Interventional Devices Sales by Type (2017-2022) & (K Units)
Table 74. Asia Pacific Neurovascular Interventional Devices Sales by Type (2023-2028) & (K Units)
Table 75. Asia Pacific Neurovascular Interventional Devices Revenue by Type (2017-2022) & (US$ Million)
Table 76. Asia Pacific Neurovascular Interventional Devices Revenue by Type (2023-2028) & (US$ Million)
Table 77. Asia Pacific Neurovascular Interventional Devices Sales by Application (2017-2022) & (K Units)
Table 78. Asia Pacific Neurovascular Interventional Devices Sales by Application (2023-2028) & (K Units)
Table 79. Asia Pacific Neurovascular Interventional Devices Revenue by Application (2017-2022) & (US$ Million)
Table 80. Asia Pacific Neurovascular Interventional Devices Revenue by Application (2023-2028) & (US$ Million)
Table 81. Asia Pacific Neurovascular Interventional Devices Sales by Region (2017-2022) & (K Units)
Table 82. Asia Pacific Neurovascular Interventional Devices Sales by Region (2023-2028) & (K Units)
Table 83. Asia Pacific Neurovascular Interventional Devices Revenue by Region (2017-2022) & (US$ Million)
Table 84. Asia Pacific Neurovascular Interventional Devices Revenue by Region (2023-2028) & (US$ Million)
Table 85. Latin America Neurovascular Interventional Devices Sales by Type (2017-2022) & (K Units)
Table 86. Latin America Neurovascular Interventional Devices Sales by Type (2023-2028) & (K Units)
Table 87. Latin America Neurovascular Interventional Devices Revenue by Type (2017-2022) & (US$ Million)
Table 88. Latin America Neurovascular Interventional Devices Revenue by Type (2023-2028) & (US$ Million)
Table 89. Latin America Neurovascular Interventional Devices Sales by Application (2017-2022) & (K Units)
Table 90. Latin America Neurovascular Interventional Devices Sales by Application (2023-2028) & (K Units)
Table 91. Latin America Neurovascular Interventional Devices Revenue by Application (2017-2022) & (US$ Million)
Table 92. Latin America Neurovascular Interventional Devices Revenue by Application (2023-2028) & (US$ Million)
Table 93. Latin America Neurovascular Interventional Devices Sales by Country (2017-2022) & (K Units)
Table 94. Latin America Neurovascular Interventional Devices Sales by Country (2023-2028) & (K Units)
Table 95. Latin America Neurovascular Interventional Devices Revenue by Country (2017-2022) & (US$ Million)
Table 96. Latin America Neurovascular Interventional Devices Revenue by Country (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Neurovascular Interventional Devices Sales by Type (2017-2022) & (K Units)
Table 98. Middle East and Africa Neurovascular Interventional Devices Sales by Type (2023-2028) & (K Units)
Table 99. Middle East and Africa Neurovascular Interventional Devices Revenue by Type (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Neurovascular Interventional Devices Revenue by Type (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Neurovascular Interventional Devices Sales by Application (2017-2022) & (K Units)
Table 102. Middle East and Africa Neurovascular Interventional Devices Sales by Application (2023-2028) & (K Units)
Table 103. Middle East and Africa Neurovascular Interventional Devices Revenue by Application (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Neurovascular Interventional Devices Revenue by Application (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Neurovascular Interventional Devices Sales by Country (2017-2022) & (K Units)
Table 106. Middle East and Africa Neurovascular Interventional Devices Sales by Country (2023-2028) & (K Units)
Table 107. Middle East and Africa Neurovascular Interventional Devices Revenue by Country (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Neurovascular Interventional Devices Revenue by Country (2023-2028) & (US$ Million)
Table 109. W.L. Gore & Associates Corporation Information
Table 110. W.L. Gore & Associates Description and Major Businesses
Table 111. W.L. Gore & Associates Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. W.L. Gore & Associates Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. W.L. Gore & Associates Recent Developments
Table 114. Abbott Laboratories Corporation Information
Table 115. Abbott Laboratories Description and Major Businesses
Table 116. Abbott Laboratories Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Abbott Laboratories Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Abbott Laboratories Recent Developments
Table 119. Stryker Corporation Corporation Information
Table 120. Stryker Corporation Description and Major Businesses
Table 121. Stryker Corporation Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Stryker Corporation Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Stryker Corporation Recent Developments
Table 124. Medtronic PLC Corporation Information
Table 125. Medtronic PLC Description and Major Businesses
Table 126. Medtronic PLC Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Medtronic PLC Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Medtronic PLC Recent Developments
Table 129. Terumo Corporation Corporation Information
Table 130. Terumo Corporation Description and Major Businesses
Table 131. Terumo Corporation Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Terumo Corporation Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Terumo Corporation Recent Developments
Table 134. Johnson & Johnson Corporation Information
Table 135. Johnson & Johnson Description and Major Businesses
Table 136. Johnson & Johnson Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Johnson & Johnson Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Johnson & Johnson Recent Developments
Table 139. Penumbra, Inc. Corporation Information
Table 140. Penumbra, Inc. Description and Major Businesses
Table 141. Penumbra, Inc. Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. Penumbra, Inc. Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Penumbra, Inc. Recent Developments
Table 144. Boston Scientific Corporation Corporation Information
Table 145. Boston Scientific Corporation Description and Major Businesses
Table 146. Boston Scientific Corporation Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. Boston Scientific Corporation Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Boston Scientific Corporation Recent Developments
Table 149. Merit Medical Systems, Inc. Corporation Information
Table 150. Merit Medical Systems, Inc. Description and Major Businesses
Table 151. Merit Medical Systems, Inc. Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 152. Merit Medical Systems, Inc. Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Merit Medical Systems, Inc. Recent Developments
Table 154. Microport Scientific Corporation Corporation Information
Table 155. Microport Scientific Corporation Description and Major Businesses
Table 156. Microport Scientific Corporation Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 157. Microport Scientific Corporation Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Microport Scientific Corporation Recent Developments
Table 159. Cardinal Health Corporation Information
Table 160. Cardinal Health Description and Major Businesses
Table 161. Cardinal Health Neurovascular Interventional Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 162. Cardinal Health Neurovascular Interventional Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Cardinal Health Recent Developments
Table 164. Key Raw Materials Lists
Table 165. Raw Materials Key Suppliers Lists
Table 166. Neurovascular Interventional Devices Distributors List
Table 167. Neurovascular Interventional Devices Customers List
Table 168. Neurovascular Interventional Devices Market Trends
Table 169. Neurovascular Interventional Devices Market Drivers
Table 170. Neurovascular Interventional Devices Market Challenges
Table 171. Neurovascular Interventional Devices Market Restraints
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Neurovascular Interventional Devices Product Picture
Figure 3. Global Neurovascular Interventional Devices Market Share by Type in 2021 & 2028
Figure 3. Embolization Coils Product Picture
Figure 4. Carotid Stents Product Picture
Figure 5. Intracranial Stents Product Picture
Figure 6. Flow Diverters Product Picture
Figure 7. Intrasaccular Devices Product Picture
Figure 8. Others Product Picture
Figure 9. Global Neurovascular Interventional Devices Market Share by Application in 2021 & 2028
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Ambulatory Surgical Centers
Figure 13. Others
Figure 14. Neurovascular Interventional Devices Report Years Considered
Figure 15. Global Neurovascular Interventional Devices Sales 2017-2028 (K Units)
Figure 16. Global Neurovascular Interventional Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Neurovascular Interventional Devices Revenue 2017-2028 (US$ Million)
Figure 18. Global Neurovascular Interventional Devices Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global Neurovascular Interventional Devices Sales Market Share by Region (2017-2022)
Figure 20. Global Neurovascular Interventional Devices Sales Market Share by Region (2023-2028)
Figure 21. North America Neurovascular Interventional Devices Sales YoY (2017-2028) & (K Units)
Figure 22. North America Neurovascular Interventional Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe Neurovascular Interventional Devices Sales YoY (2017-2028) & (K Units)
Figure 24. Europe Neurovascular Interventional Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific Neurovascular Interventional Devices Sales YoY (2017-2028) & (K Units)
Figure 26. Asia-Pacific Neurovascular Interventional Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America Neurovascular Interventional Devices Sales YoY (2017-2028) & (K Units)
Figure 28. Latin America Neurovascular Interventional Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa Neurovascular Interventional Devices Sales YoY (2017-2028) & (K Units)
Figure 30. Middle East & Africa Neurovascular Interventional Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The Neurovascular Interventional Devices Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of Neurovascular Interventional Devices in the World: Market Share by Neurovascular Interventional Devices Revenue in 2021
Figure 33. Global Neurovascular Interventional Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global Neurovascular Interventional Devices Sales Market Share by Type (2017-2028)
Figure 35. Global Neurovascular Interventional Devices Revenue Market Share by Type (2017-2028)
Figure 36. Global Neurovascular Interventional Devices Sales Market Share by Application (2017-2028)
Figure 37. Global Neurovascular Interventional Devices Revenue Market Share by Application (2017-2028)
Figure 38. North America Neurovascular Interventional Devices Sales Market Share by Type (2017-2028)
Figure 39. North America Neurovascular Interventional Devices Revenue Market Share by Type (2017-2028)
Figure 40. North America Neurovascular Interventional Devices Sales Market Share by Application (2017-2028)
Figure 41. North America Neurovascular Interventional Devices Revenue Market Share by Application (2017-2028)
Figure 42. North America Neurovascular Interventional Devices Sales Share by Country (2017-2028)
Figure 43. North America Neurovascular Interventional Devices Revenue Share by Country (2017-2028)
Figure 44. United States Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 45. Canada Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 46. Europe Neurovascular Interventional Devices Sales Market Share by Type (2017-2028)
Figure 47. Europe Neurovascular Interventional Devices Revenue Market Share by Type (2017-2028)
Figure 48. Europe Neurovascular Interventional Devices Sales Market Share by Application (2017-2028)
Figure 49. Europe Neurovascular Interventional Devices Revenue Market Share by Application (2017-2028)
Figure 50. Europe Neurovascular Interventional Devices Sales Share by Country (2017-2028)
Figure 51. Europe Neurovascular Interventional Devices Revenue Share by Country (2017-2028)
Figure 52. Germany Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 53. France Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 54. U.K. Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 55. Italy Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 56. Russia Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific Neurovascular Interventional Devices Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific Neurovascular Interventional Devices Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific Neurovascular Interventional Devices Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific Neurovascular Interventional Devices Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific Neurovascular Interventional Devices Sales Share by Region (2017-2028)
Figure 62. Asia Pacific Neurovascular Interventional Devices Revenue Share by Region (2017-2028)
Figure 63. China Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 64. Japan Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 66. India Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 67. Australia Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 68. China Taiwan Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 69. Indonesia Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 70. Thailand Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 71. Malaysia Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 72. Latin America Neurovascular Interventional Devices Sales Market Share by Type (2017-2028)
Figure 73. Latin America Neurovascular Interventional Devices Revenue Market Share by Type (2017-2028)
Figure 74. Latin America Neurovascular Interventional Devices Sales Market Share by Application (2017-2028)
Figure 75. Latin America Neurovascular Interventional Devices Revenue Market Share by Application (2017-2028)
Figure 76. Latin America Neurovascular Interventional Devices Sales Share by Country (2017-2028)
Figure 77. Latin America Neurovascular Interventional Devices Revenue Share by Country (2017-2028)
Figure 78. Mexico Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 79. Brazil Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 80. Argentina Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa Neurovascular Interventional Devices Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Neurovascular Interventional Devices Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Neurovascular Interventional Devices Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Neurovascular Interventional Devices Revenue Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Neurovascular Interventional Devices Sales Share by Country (2017-2028)
Figure 86. Middle East and Africa Neurovascular Interventional Devices Revenue Share by Country (2017-2028)
Figure 87. Turkey Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 88. Saudi Arabia Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 89. UAE Neurovascular Interventional Devices Revenue (2017-2028) & (US$ Million)
Figure 90. Neurovascular Interventional Devices Value Chain
Figure 91. Neurovascular Interventional Devices Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed